Roeske WR - Search Results

1

Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor.

Quock RM, Hosohata Y, Knapp RJ, Burkey TH, Hosohata K, Zhang X, Rice KC, Nagase H, Hruby VJ, Porreca F, Roeske WR, Yamamura HI. Quock RM, et al. Among authors: roeske wr. Eur J Pharmacol. 1997 May 12;326(1):101-4. doi: 10.1016/s0014-2999(97)83488-7. Eur J Pharmacol. 1997. PMID: 9178661

2

Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation.

Varga EV, Rubenzik M, Grife V, Sugiyama M, Stropova D, Roeske WR, Yamamura HI. Varga EV, et al. Among authors: roeske wr. Eur J Pharmacol. 2002 Sep 6;451(1):101-2. doi: 10.1016/s0014-2999(02)02220-3. Eur J Pharmacol. 2002. PMID: 12223234

3

Agonist-specific down-regulation of the human delta-opioid receptor.

Okura T, Varga EV, Hosohata Y, Navratilova E, Cowell SM, Rice K, Nagase H, Hruby VJ, Roeske WR, Yamamura HI. Okura T, et al. Among authors: roeske wr. Eur J Pharmacol. 2003 Jan 10;459(1):9-16. doi: 10.1016/s0014-2999(02)02823-6. Eur J Pharmacol. 2003. PMID: 12505529

4

(2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.

Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI. Hosohata K, et al. Among authors: roeske wr. J Pharmacol Exp Ther. 2003 Feb;304(2):683-8. doi: 10.1124/jpet.102.042929. J Pharmacol Exp Ther. 2003. PMID: 12538822

5

Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment.

Varga EV, Rubenzik MK, Stropova D, Sugiyama M, Grife V, Hruby VJ, Rice KC, Roeske WR, Yamamura HI. Varga EV, et al. Among authors: roeske wr. J Pharmacol Exp Ther. 2003 Jul;306(1):109-15. doi: 10.1124/jpet.103.049643. Epub 2003 Mar 26. J Pharmacol Exp Ther. 2003. PMID: 12660310

6

Mutation S363A in the human delta-opioid receptor selectively reduces down-regulation by a peptide agonist.

Navratilova E, Varga EV, Stropova D, Jambrosic JC, Roeske WR, Yamamura HI. Navratilova E, et al. Among authors: roeske wr. Eur J Pharmacol. 2004 Feb 6;485(1-3):341-3. doi: 10.1016/j.ejphar.2003.11.067. Eur J Pharmacol. 2004. PMID: 14757159

7

Morphine promotes phosphorylation of the human delta-opioid receptor at serine 363.

Navratilova E, Eaton MC, Stropova D, Varga EV, Vanderah TW, Roeske WR, Yamamura HI. Navratilova E, et al. Among authors: roeske wr. Eur J Pharmacol. 2005 Sep 20;519(3):212-4. doi: 10.1016/j.ejphar.2005.07.024. Eur J Pharmacol. 2005. PMID: 16135360

8

Quantitative evaluation of human delta opioid receptor desensitization using the operational model of drug action.

Navratilova E, Waite S, Stropova D, Eaton MC, Alves ID, Hruby VJ, Roeske WR, Yamamura HI, Varga EV. Navratilova E, et al. Among authors: roeske wr. Mol Pharmacol. 2007 May;71(5):1416-26. doi: 10.1124/mol.106.030023. Epub 2007 Feb 22. Mol Pharmacol. 2007. PMID: 17322005

9

Human delta opioid receptor: a stable cell line for functional studies of opioids.

Malatynska E, Wang Y, Knapp RJ, Santoro G, Li X, Waite S, Roeske WR, Yamamura HI. Malatynska E, et al. Among authors: roeske wr. Neuroreport. 1995 Mar 7;6(4):613-6. Neuroreport. 1995. PMID: 7605911

10

Molecular biology and pharmacology of cloned opioid receptors.

Knapp RJ, Malatynska E, Collins N, Fang L, Wang JY, Hruby VJ, Roeske WR, Yamamura HI. Knapp RJ, et al. Among authors: roeske wr. FASEB J. 1995 Apr;9(7):516-25. doi: 10.1096/fasebj.9.7.7737460. FASEB J. 1995. PMID: 7737460 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page